Literature DB >> 20842047

Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension.

Paolo Manunta1, John M Hamlyn, Marco Simonini, Elisabetta Messaggio, Chiara Lanzani, Maria Bracale, Giuseppe Argiolas, Nunzia Casamassima, Elena Brioni, Nicola Glorioso, Giuseppe Bianchi.   

Abstract

OBJECTIVE: To evaluate whether the renin-angiotensin-aldosterone system (RAAS) and endogenous ouabain system differently affect renal Na handling and blood pressure.
METHODS: Three hundred and one patients in whom we compared blood pressure, and renal Na tubular reabsorption in the basal condition and 2 h (T120) after saline infusion.
RESULTS: Following multivariate-adjusted linear and quartiles analysis, baseline mean blood pressure (MBP) was significantly higher (113.7 ± 1.33 mmHg) in the fourth versus the first endogenous ouabain quartile (103.8 ± 1.04 mmHg) and the trend across the quartiles was highly significant (β = 0.23, P = 3.53e-04). In contrast, an inverse relationship was present in the renin activity (PRA) quartiles with MBP highest in the first (112.5 ± 1.26) and lowest in the fourth PRA quartile (107.6 ± 1.48, P = 0.039). Following an acute saline load, changes in MBP and the slope of the pressure-natriuresis relationship were inversely related across the PRA quartiles. The fractional excretion of sodium (FENa) showed a negative linear trend going from the first to the third endogenous ouabain quartiles (2.35 ± 0.17 and 1.90 ± 0.14%, P = 0.05). Patients in the fourth endogenous ouabain quartile (>323 pmol/l) showed increased FENa T120 (2.78 ± 0.18%, P < 0.01) and increased Na tubular rejection fraction (P = 0.007) after Na load. After the saline load, there was a biphasic relationship between plasma endogenous ouabain and FENa favoring Na retention at low endogenous ouabain and Na excretion at high endogenous ouabain levels.
CONCLUSION: The RAAS and endogenous ouabain system are two independent and complementary systems having an inverse (RAAS) or a direct (endogenous ouabain system) relationship with hemodynamic parameters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20842047      PMCID: PMC3521520          DOI: 10.1097/HJH.0b013e32833ea821

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  30 in total

Review 1.  Salt--a potential 'uremic toxin'?

Authors:  Eberhard Ritz; Ralf Dikow; Christian Morath; Vedat Schwenger
Journal:  Blood Purif       Date:  2006       Impact factor: 2.614

2.  Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells.

Authors:  J R Shah; J Laredo; B P Hamilton; J M Hamlyn
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

Review 3.  The genetic dissection of essential hypertension.

Authors:  Allen W Cowley
Journal:  Nat Rev Genet       Date:  2006-10-10       Impact factor: 53.242

4.  Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice.

Authors:  Jin Zhang; Moo Yeol Lee; Maurizio Cavalli; Ling Chen; Roberto Berra-Romani; C William Balke; Giuseppe Bianchi; Patrizia Ferrari; John M Hamlyn; Takahiro Iwamoto; Jerry B Lingrel; Donald R Matteson; W Gil Wier; Mordecai P Blaustein
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

Review 5.  Pathogenesis of salt sensitivity of blood pressure.

Authors:  Myron H Weinberger
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

6.  PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain.

Authors:  P Ferrari; L Torielli; M Ferrandi; G Padoani; L Duzzi; M Florio; F Conti; P Melloni; L Vesci; N Corsico; G Bianchi
Journal:  J Pharmacol Exp Ther       Date:  1998-04       Impact factor: 4.030

7.  Plasma sodium: ignored and underestimated.

Authors:  Feng J He; Nirmala D Markandu; Giuseppe A Sagnella; Hugh E de Wardener; Graham A MacGregor
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

8.  Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.

Authors:  M Ferrandi; P Manunta; S Balzan; J M Hamlyn; G Bianchi; P Ferrari
Journal:  Hypertension       Date:  1997-10       Impact factor: 10.190

Review 9.  Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension.

Authors:  M Ferrandi; I Molinari; G Bianchi; P Ferrari
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-12-30       Impact factor: 1.770

10.  Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients.

Authors:  P Manunta; D Cusi; C Barlassina; M Righetti; C Lanzani; M D'Amico; L Buzzi; L Citterio; P Stella; R Rivera; G Bianchi
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

View more
  17 in total

Review 1.  Endogenous ouabain: a link between sodium intake and hypertension.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 2.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 3.  Hemodialysis-induced cardiovascular disease.

Authors:  Shadi Ahmadmehrabi; W H Wilson Tang
Journal:  Semin Dial       Date:  2018-04-06       Impact factor: 3.455

Review 4.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

5.  A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain.

Authors:  Marco Simonini; Chiara Lanzani; Elena Bignami; Nunzia Casamassima; Elena Frati; Roberta Meroni; Elisabetta Messaggio; Ottavio Alfieri; John Hamlyn; Simon C Body; C David Collard; Alberto Zangrillo; Paolo Manunta
Journal:  Nephrol Dial Transplant       Date:  2014-06-11       Impact factor: 5.992

6.  Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?

Authors:  Cristina I Linde; Laura K Antos; Vera A Golovina; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-27       Impact factor: 4.733

7.  Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients.

Authors:  Elena Bignami; Nunzia Casamassima; Elena Frati; Chiara Lanzani; Laura Corno; Ottavio Alfieri; Stephen Gottlieb; Marco Simonini; Keyur B Shah; Anna Mizzi; Elisabetta Messaggio; Alberto Zangrillo; Mara Ferrandi; Patrizia Ferrari; Giuseppe Bianchi; John M Hamlyn; Paolo Manunta
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

Review 8.  Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension.

Authors:  Rossella Iatrino; Paolo Manunta; Laura Zagato
Journal:  Curr Hypertens Rep       Date:  2016-09       Impact factor: 5.369

9.  Ouabain-digoxin antagonism in rat arteries and neurones.

Authors:  Hong Song; Eiji Karashima; John M Hamlyn; Mordecai P Blaustein
Journal:  J Physiol       Date:  2013-12-16       Impact factor: 5.182

10.  Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake.

Authors:  Chiara Lanzani; Guido Gatti; Lorena Citterio; Elisabetta Messaggio; Simona Delli Carpini; Marco Simonini; Nunzia Casamassima; Laura Zagato; Elena Brioni; John M Hamlyn; Paolo Manunta
Journal:  Hypertension       Date:  2015-12-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.